These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 10985797)
1. Redox potential measurements of the Mycobacterium tuberculosis heme protein KatG and the isoniazid-resistant enzyme KatG(S315T): insights into isoniazid activation. Wengenack NL; Lopes H; Kennedy MJ; Tavares P; Pereira AS; Moura I; Moura JJ; Rusnak F Biochemistry; 2000 Sep; 39(37):11508-13. PubMed ID: 10985797 [TBL] [Abstract][Full Text] [Related]
2. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Wengenack NL; Todorovic S; Yu L; Rusnak F Biochemistry; 1998 Nov; 37(45):15825-34. PubMed ID: 9843388 [TBL] [Abstract][Full Text] [Related]
3. Carbon monoxide adducts of KatG and KatG(S315T) as probes of the heme site and isoniazid binding. Lukat-Rodgers GS; Wengenack NL; Rusnak F; Rodgers KR Biochemistry; 2001 Jun; 40(24):7149-57. PubMed ID: 11401561 [TBL] [Abstract][Full Text] [Related]
4. Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). Wengenack NL; Rusnak F Biochemistry; 2001 Jul; 40(30):8990-6. PubMed ID: 11467961 [TBL] [Abstract][Full Text] [Related]
5. Conformational differences in Mycobacterium tuberculosis catalase-peroxidase KatG and its S315T mutant revealed by resonance Raman spectroscopy. Kapetanaki S; Chouchane S; Girotto S; Yu S; Magliozzo RS; Schelvis JP Biochemistry; 2003 Apr; 42(13):3835-45. PubMed ID: 12667074 [TBL] [Abstract][Full Text] [Related]
6. Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. Yu S; Girotto S; Lee C; Magliozzo RS J Biol Chem; 2003 Apr; 278(17):14769-75. PubMed ID: 12586821 [TBL] [Abstract][Full Text] [Related]
7. Spectroscopic comparison of the heme active sites in WT KatG and its S315T mutant. Lukat-Rodgers GS; Wengenack NL; Rusnak F; Rodgers KR Biochemistry; 2000 Aug; 39(32):9984-93. PubMed ID: 10933819 [TBL] [Abstract][Full Text] [Related]
8. Variations in the occurrence of the S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Abal AT; Ahmad S; Mokaddas E Microb Drug Resist; 2002; 8(2):99-105. PubMed ID: 12118524 [TBL] [Abstract][Full Text] [Related]
9. Resonance Raman spectroscopy of Compound II and its decay in Mycobacterium tuberculosis catalase-peroxidase KatG and its isoniazid resistant mutant S315T. Kapetanaki SM; Chouchane S; Yu S; Magliozzo RS; Schelvis JP J Inorg Biochem; 2005 Jun; 99(6):1401-6. PubMed ID: 15917090 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG). Suarez J; Ranguelova K; Schelvis JPM; Magliozzo RS J Biol Chem; 2009 Jun; 284(24):16146-16155. PubMed ID: 19363028 [TBL] [Abstract][Full Text] [Related]
11. Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. Wengenack NL; Uhl JR; St Amand AL; Tomlinson AJ; Benson LM; Naylor S; Kline BC; Cockerill FR; Rusnak F J Infect Dis; 1997 Sep; 176(3):722-7. PubMed ID: 9291321 [TBL] [Abstract][Full Text] [Related]
12. Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB. Ghiladi RA; Cabelli DE; Ortiz de Montellano PR J Am Chem Soc; 2004 Apr; 126(15):4772-3. PubMed ID: 15080669 [TBL] [Abstract][Full Text] [Related]
13. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of S315T mutation within the katG gene in isoniazid-resistant clinical Mycobacterium tuberculosis isolates from Dubai and Beirut. Ahmad S; Fares E; Araj GF; Chugh TD; Mustafa AS Int J Tuberc Lung Dis; 2002 Oct; 6(10):920-6. PubMed ID: 12365580 [TBL] [Abstract][Full Text] [Related]
15. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Mokrousov I; Narvskaya O; Otten T; Limeschenko E; Steklova L; Vyshnevskiy B Antimicrob Agents Chemother; 2002 May; 46(5):1417-24. PubMed ID: 11959577 [TBL] [Abstract][Full Text] [Related]
16. Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid. Bulatovic VM; Wengenack NL; Uhl JR; Hall L; Roberts GD; Cockerill FR; Rusnak F Antimicrob Agents Chemother; 2002 Sep; 46(9):2765-71. PubMed ID: 12183226 [TBL] [Abstract][Full Text] [Related]
17. [Defining of gene mutations and minimal inhibitory concentrations in isoniazid resistant Mycobacterium tuberculosis isolates]. Yıldırım E; Uzun M Mikrobiyol Bul; 2017 Oct; 51(4):305-316. PubMed ID: 29153061 [TBL] [Abstract][Full Text] [Related]